Psi Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Psi Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $1,440 - $2,730	1,000 New	1,000 $2,000
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $1,900 - $4,980	-1,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.95 - $5.35 $3,950 - $5,350	1,000 New	1,000 $4,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Psi Advisors, LLC with notifications on news.